Clinical Trial Update: A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SSGJ-707 in metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SSGJ-707

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING